Search Results - "BONILLA, M. A"

Refine Results
  1. 1

    Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy by Kushner, B H, LaQuaglia, M P, Wollner, N, Meyers, P A, Lindsley, K L, Ghavimi, F, Merchant, T E, Boulad, F, Cheung, N K, Bonilla, M A, Crouch, G, Kelleher, Jr, J F, Steinherz, P G, Gerald, W L

    Published in Journal of clinical oncology (01-05-1996)
    “…To test intensive alkylator-based therapy in desmoplastic small round-cell tumor (DSRCT). Patients received the P6 protocol, which has seven courses of…”
    Get more information
    Journal Article
  2. 2

    Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy by FREEDMAN, M. H, BONILLA, M. A, MORI, P. G, COTTLE, T, WELTE, K, DALE, D. C, FIER, C, BOLYARD, A. A, SCARLATA, D, BOXER, L. A, BROWN, S, CHAM, B, KANNOURAKIS, G, KINSEY, S. E

    Published in Blood (15-07-2000)
    “…Granulocyte colony-stimulating factor (G-CSF) has had a major impact on management of "severe chronic neutropenia," a collective term referring to congenital,…”
    Get full text
    Journal Article
  3. 3

    Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias by Bonilla, M A, Dale, D, Zeidler, C, Last, L, Reiter, A, Ruggeiro, M, Davis, M, Koci, B, Hammond, W, Gillio, A, Welte, Karl

    Published in British journal of haematology (01-12-1994)
    “…Congenital neutropenias include a heterogenous group of diseases characterized by a decrease in circulating neutrophils. In phase I/II/III studies in patients…”
    Get more information
    Journal Article
  4. 4

    Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia by DONG, F, DALE, D. C, WELTE, K, LÖWENBERG, B, TOUW, I. P, BONILLA, M. A, FREEDMAN, M, FASTH, A, NEIJENS, H. J, PALMBLAD, J, BRIARS, G. L, CARLSSON, G, VEERMAN, A. J. P

    Published in Leukemia (1997)
    “…Previously, nonsense mutations in the gene encoding the granulocyte colony-stimulating factor receptor (G-CSF-R) have been described in three patients with…”
    Get full text
    Journal Article
  5. 5

    Antibiotic‐resistant Staphylococcus aureus strains of swine origin: molecular typing and susceptibility to oregano (Origanum vulgare L.) essential oil and maqui (Aristotelia chilensis (Molina) Stuntz) extract by Lofa, A., Velasco, V., Gerding, M., López, M.D., Vallejos, D., Bonilla, A.M., Logue, C.M.

    Published in Journal of applied microbiology (01-10-2019)
    “…Aim The molecular typing and the susceptibility of Staphylococcus aureus strains of swine origin to antibiotics, oregano (Origanum vulgare L.) essential oil…”
    Get full text
    Journal Article
  6. 6

    Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age by Kushner, B H, LaQuaglia, M P, Bonilla, M A, Lindsley, K, Rosenfield, N, Yeh, S, Eddy, J, Gerald, W L, Heller, G, Cheung, N K

    Published in Journal of clinical oncology (01-12-1994)
    “…To test the efficacy of a protocol for poor-risk neuroblastoma that builds on the following: (1) our favorable previously reported results with dose-intensive…”
    Get more information
    Journal Article
  7. 7

    Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy by Kushner, B H, Cheung, N K, LaQuaglia, M P, Ambros, P F, Ambros, I M, Bonilla, M A, Gerald, W L, Ladanyi, M, Gilbert, F, Rosenfield, N S, Yeh, S D

    Published in Journal of clinical oncology (01-02-1996)
    “…To test the hypothesis that cytotoxic therapy is not needed at diagnosis to assure the survival of most patients with non-stage 4 neuroblastoma. Patients with…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Monosomy 7 and Activating RAS Mutations Accompany Malignant Transformation in Patients With Congenital Neutropenia by Kalra, Ruby, Dale, David, Freedman, Melvin, Bonilla, Mary Ann, Weinblatt, Mark, Ganser, Arnold, Bowman, Paul, Abish, Sharon, Priest, Jack, Oseas, Ronald S., Olson, Kristin, Paderanga, Dorothy, Shannon, Kevin

    Published in Blood (15-12-1995)
    “…Individuals with severe forms of congenital neutropenia suffer from recurrent infections. The therapeutic use of recombinant human granulocyte…”
    Get full text
    Journal Article
  10. 10

    Recombinant human granulocyte colony-stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates by WELTE, K, BONILLA, M. A, GILLIO, A. P, BOONE, T. C, POTTER, G. K, GABRILOVE, J. L, MOORE, M. A. S, O'REILLY, R. J, SOUZA, L. M

    Published in The Journal of experimental medicine (01-04-1987)
    “…We examined the in vivo effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in primates (cynomolgus monkeys) treated with subcutaneous…”
    Get full text
    Journal Article
  11. 11

    Chemotactic Activity of Recombinant Human Granulocyte Colony-Stimulating Factor by Wang, Ji Ming, Chen, Zhen Guo, Colella, Silvia, Bonilla, Mary Ann, Welte, Karl, Bordignon, Claudio, Mantovani, Alberto

    Published in Blood (01-11-1988)
    “…Recombinant human granulocyte colony-stimulating factor (rhG-CSF) induced migration across polycarbonate filters of human polymorphonuclear leukocytes (PMN)…”
    Get full text
    Journal Article
  12. 12

    Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium by GABRILOVE, J. L, JAKUBOWSKI, A, ALTON, K, BOONE, T, ALTROCK, B, WELTE, K, SOUZA, L, FAIN, K, GROUS, J, SCHER, H, STERNBERG, C, YAGODA, A, CLARKSON, B, BONILLA, M. A, OETTGEN, H. F

    Published in The Journal of clinical investigation (01-10-1988)
    “…Recombinant human granulocyte colony-stimulating factor (rhG-CSF) was administered at a dose of 1-60 micrograms/kg of body weight to 22 patients with…”
    Get full text
    Journal Article
  13. 13

    International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review by Kushner, B H, Cheung, N K, LaQuaglia, M P, Ambros, P F, Ambros, I M, Bonilla, M A, Ladanyi, M, Gerald, W L

    Published in Journal of clinical oncology (01-07-1996)
    “…To gain insight into the management of non-metastatic neuroblastoma by examining clinical and biologic features of International Neuroblastoma Staging System…”
    Get more information
    Journal Article
  14. 14

    Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis by Bonilla, M A, Gillio, A P, Ruggeiro, M, Kernan, N A, Brochstein, J A, Abboud, M, Fumagalli, L, Vincent, M, Gabrilove, J L, Welte, K

    Published in The New England journal of medicine (15-06-1989)
    “…Congenital agranulocytosis is a disorder characterized by severe neutropenia and a profound deficiency of identifiable neutrophil progenitors in bone marrow…”
    Get more information
    Journal Article
  15. 15

    Entomofauna resource distribution associated with pig cadavers in Bogotá DC by SEGURA, N.A, BONILLA, M.A, USAQUÉN, W, BELLO, F

    Published in Medical and veterinary entomology (01-03-2011)
    “…A cadaver represents a temporal energy-loaded resource, which provides arthropods with food, protection and a place in which to find a mate. Insects are…”
    Get full text
    Journal Article
  16. 16

    Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia by Dale, David C., Person, Richard E., Bolyard, Audrey Anna, Aprikyan, Andrew G., Bos, Cindy, Bonilla, Mary Ann, Boxer, Laurence A., Kannourakis, George, Zeidler, Cornelia, Welte, Karl, Benson, Kathleen F., Horwitz, Marshall

    Published in Blood (01-10-2000)
    “…Congenital neutropenia and cyclic neutropenia are disorders of neutrophil production predisposing patients to recurrent bacterial infections. Recently the…”
    Get full text
    Journal Article
  17. 17

    Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers by Cheung, N.-K.V, Kushner, B.H, LaQuaglia, M.P, Kramer, K, Ambros, P, Ambros, I, Ladanyi, M, Eddy, J, Bonilla, M.-A, Gerald, W

    Published in European journal of cancer (1990) (01-10-1997)
    “…The clinical characteristics of 43 patients (pts) and the biological features of their non-stage 4 neuroblastoma (11, 3, 15, 7 and 7 with stages 1, 2A, 2B, 3…”
    Get full text
    Journal Article
  18. 18

    Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age by Cheung, N K, Kushner, B H, Cheung, I Y, Kramer, K, Canete, A, Gerald, W, Bonilla, M A, Finn, R, Yeh, S J, Larson, S M

    Published in Journal of clinical oncology (01-09-1998)
    “…To eradicate minimal residual disease with anti-G(D2) monoclonal antibody 3F8 in stage 4 neuroblastoma (NB) diagnosed at more than 1 year of age. Thirty-four…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Taenia crassiceps Cysticercosis: Humoral Immune Response and Protection Elicited by DNA Immunization by Rosas, Gabriela, Cruz-Revilla, Carmen, Fragoso, Gladis, López-Casillas, Fernando, Pérez, Armando, Bonilla, Marco Antonio, Rosales, Ricardo, Sciutto, Edda

    Published in The Journal of parasitology (01-06-1998)
    “…The purpose of this study was to evaluate DNA vaccination in cysticercosis prevention by using a Taenia crassiceps cDNA of a recombinant antigen (KETc7) that…”
    Get full text
    Journal Article